A streamlined drug-to-antibody ratio determination workflow for intact and deglycosylated antibody-drug conjugates

Applications | 2019 | Agilent TechnologiesInstrumentation
Sample Preparation, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Determination of Drug-to-Antibody Ratio for Antibody-Drug Conjugates Purified from Serum
Intact & Subunit Analysis Using Reversed Phase - Agilent BioHPLC Columns Application Compendium
An Integrated Workflow for Intact and Subunits of Monoclonal Antibody Accurate Mass Measurements
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
2026|Agilent Technologies|Brochures and specificationsApplications